Skip to main content
International Journal of Public Health logoLink to International Journal of Public Health
. 2023 Jul 11;68:1605284. doi: 10.3389/ijph.2023.1605284

Human Papillomavirus and Retinoblastoma: Evidence From a Systematic Review and Meta-analysis of Cross-Sectional Studies

Hong Feng 1, Yuan Deng 2,*
PMCID: PMC10366381  PMID: 37497122

Abstract

Objectives: To study the prevalence and the association of HPV infection in retinoblastoma and to determine the most common genotype presented in RB.

Methods: Following the PRIMSA guideline, 14 studies reporting HPV infection in RB acquired from six databases were included.

Results: The prevalence of HPV from 941 RB samples was 15.6% [95% confidence interval (CI): 7.3–30]. Mexico followed by India and Brazil had the highest HPV prevalence in RB samples, 61.7% (95% CI: 17–93), 22.5% (95% CI: 9–47), and 12.1% (95% CI: 2–52), in order. HPV 16 was the most common genotype presented in RB samples 23% (95% CI: 9–47), followed by HPV 18 10% (95% CI: 3–30) and the combined HPV 16–18 6% (95% CI: 0–50). We did not find a significant association between HPV and RB [odds ratio (OR): 12.2; 95% CI: 0.65–232; p = 0.09]. However, after removing the largest-weighted study, a significant association between HPV and RB was observed (OR: 45.9; 95% CI; 8.6–245; p < 0.001).

Conclusion: HPV prevalence in RB samples was 15% and HPV 16 was the most presented genotype in RB samples. There may be an association between HPV and RB that is needed to be confirmed by high quality future studies. Preventive and treatment measures against HPV infection are essential for the prevention of any possible consequences, in particular, RB.

Keywords: meta-analysis, cancer, human papilloma virus, HPV, retinoblastoma

Introduction

Among all ocular tumors, retinoblastoma (RB) is known to be the major cause of intraocular tumor presented in the childhood period. The incidence of RB varies from one country to another and is estimated to affect 1 patient/20,000 individuals [1]. Single or multiple presentations of the symptoms and signs such as leukocoria, squint, decreased visual acuity, painful red eye, and orbital cellulitis in children, are considered to be the backbone for RB diagnosis in the early stage of the disease where certain investigations such as computed tomography or biopsy may be contraindicated for avoiding serious complications such as metastasis or radiation-induced second malignancy in high-risk patients [2]. In a large meta-analysis of 314 papers, an improving survival rate of RB was noticed among all countries; however, the survival rate was low in low income countries, which potentially stems from the delayed diagnosis of RB cases in it is early stage [3, 4]. Therefore, appropriate preventive and diagnostic measures should be advocated for to raise the survival rate of RB patients.

In recent years, Human papillomavirus (HPV) has become an important driver of the non-inheritable proportion of many cancers [5]. Such high potentiality for developing malignancies showcases its high ability to alternate the normal cell cycle together with the induced genetic mutations [6]. However, many studies have attempted to study the role of HPV in developing RB [79]. In a population-based study of Anand et al. [7] HPV was found in a quarter of RB samples that were obtained from Indian patients. Furthermore, the cross-sectional study of Mohan et al indicated that approximately half of RB tissues contained HPV, while HPV was absent in all the control samples [10]. However, the study of Anotoneli et al. [8] indicated that the prevalence of HPV was higher in the control sample than in the RB samples, 9% and 5%, respectively. Moreover, many studies demonstrated that no evidence of HPV was revealed in RB tissues [11, 12]. Due to the reported heterogeneity in the prevalence of HPV infection in RB and the presence or the absence of association of HPV and RB in many studies, we conducted this meta-analysis which will highlight the possible role of HPV in inducing RB.

Methods

Search Strategy

Our systematic review and meta-analysis was developed by following the guidelines of Liberati et al. [13] which are known as the PRISMA checklist. A random search was performed for retrieving the best suitable included studies for performing a search term. After the consensus was finished between the team members for selecting the best keywords; in 27 February, 2022, a search term “(retinoblastoma) AND (“human papilloma virus” OR “HPV”)” was used in all the six databases that were represented in the PRISMA flow diagram (Figure 1).

FIGURE 1.

FIGURE 1

The flow diagram of the study process (Shanghai, China. 2022).

Inclusion criteria: All papers that reported HPV infection in RB samples were included, whether reported alone or compared to a control population. We made no restrictions against the event of HPV (studies with 0 events were included), language of studies, and the publication year.

Exclusion criteria: We excluded conference papers, previous systematic reviews, books, and duplicate papers including the same patients, which were checked by reviewing the country, recruitment year, and the hospital of the included patients along with the similarity of the authors of the suspected duplicated papers.

After the search term development, one author retrieved all records from the six databases including title, abstract, link, DOI, publication year, and author list of each individual study. The process was performed by Endnote software, and then all records were transported to an Excel sheet for the screening process. Each record was screened from the excel sheet by both authors and a third reviewer when disagreement was presented. Then another step of full text screening was done by both authors for including the best matched studies according to our eligibility criteria. Two experienced members conducted a manual search to retrieve the missed relevant papers by searching the references of any previously published systematic reviews and a hand search in Google Scholar database.

Data Extraction and Risk of Bias

All the necessary data for the characteristics of the included studies and our outcomes were extracted through an Excel sheet. Our outcomes were: the prevalence of HPV in RB, the common genotype of HPV in RB, and the association between HPV and RB. The characteristics of the included studies were: study ID, male prevalence, country of patients, study design, control definition, age, and the diagnostic method of HPV. Two authors extracted the data and reviewed it for any potential errors. The online tool of the cross-sectional and the cohort studies of the National Institute of Health were retrieved and all studies were assessed for quality into good, fair, or poor domains [14].

Statistical Analysis

The software used for the analysis was comprehensive meta-analysis software (CMA 3.0). Two effect sizes were pooled, the event rate to analyze the prevalence of HPV in RB, and the odds ratio (OR) to analyze the association between HPV in RB compared to controls along with their 95% confidence interval (CI). Due to the significant heterogeneity we found, we used random effect model in all the analyzed outcomes [15]. Moreover, two tailed p values that resulted from Egger’s test were used to report the publication bias in outcomes that had ten or more included studies [16, 17].

Results

Search Results and Characteristics of the Included Studies

From the six databases, 3,264 records were retrieved and only 2,459 records were screened using title and abstract screening after excluding duplicate records. We screened 16 full texts for potential eligibility in our study. Finally, we included 14 studies that included three studies from manual search methods (Figure 1) [712, 1825].

There were 14 cross-sectional studies (Table 1). All studies used polymerase chain reaction (PCR) for the identification of HPV except one study, which used the in situ hybridization in formalin-fixed paraffin-embedded RB tissues. All studies were of fair criterion (Supplementary Table S1).

TABLE 1.

Characteristics of the included studies (Shanghai, China. 2022).

Study ID Study design Sample size RB Sample size control Definition of control Age (mean (SD)) RB diagnosis Male prevalence in RB
[7]-India Cross-sectional 64 2.5 years PCR NR
[8]-Brazil Cross-sectional 154 44 Normal retina from each embedded tissue block 22.4 months PCR 74
[9]-India Cross-sectional 72 4 years PCR 46
[18]-India Cross-sectional 106 26.7 PCR 55
[10]-India Cross-sectional 44 30 Non-neoplastic donor retinas 2 a PCR 27
[19]-Mexico Cross-sectional 51 6 Non-RB occular tissue 2 months-8 years b PCR NR
[20]-India Cross-sectional 39 42 Donor eyes obtained from the eye bank 41.8 (26.2) PCR 20
[21]-Mexico Cross-sectional 39 <5 years PCR NR
[22]-Brazil Cross-sectional 43 28.8 months (17) PCR 21
[23]-India Cross-sectional 76 36 months a PCR NR
[11]-Korea Cross-sectional 54 22 months In situ hybridization in formalin-fixed paraffin-embedded retinoblastoma tissues NR
[24]-Thailand Cross-sectional 111 12 Coats disease, endophthalmitis, and congenital glaucoma NR PCR 56
[26]-Iran Cross-sectional 61 v 28.6 years (17.3) PCR 32
[12]-Multicenter in North America Cross-sectional 40 NR PCR 23

NR, not reported; RB, retinoblastoma; PRC, polymerase chain reaction.

a

Range.

b

Range.

Prevalence of HPV in RB

Fourteen studies reported HPV prevalence in 941 RB samples. The prevalence of HPV was 15.6% (95% CI: 7.3–30) (Figure 2).

FIGURE 2.

FIGURE 2

The prevalence of Human papilloma virus in retinoblastoma (Shanghai, China. 2022). Notes: The data is represented with the event rate and the corresponding 95% confidence interval.

We performed subgroup analysis according to the country of each study. Mexico followed by India and Brazil had the highest prevalence of HPV in RB samples, 61.7% (95% CI: 17–93), 22.5% (95% CI: 9–47) and 12.1% (95% CI: 2–52), in order (Supplementary Figure S1). Moreover, studies conducted in Korea, Thailand, and the multicenter study conducted in North America, indicated that HPV was absent in all RB samples.

We found a significant publication bias in the prevalence of HPV in RB (p = 0.02) (Figure 3).

FIGURE 3.

FIGURE 3

Publication bias of the prevalence of Human papilloma virus in retinoblastoma (Shanghai, China. 2022).

Association Between HPV and RB

Five studies compared HPV prevalence in RB samples to controls [8, 10, 19, 20, 24]. However, in our analysis we included only four studies [8, 10, 19, 20] as the fifth study demonstrated no events in the RB group and the control group [24]. Therefore, the study effect size will not play a significant role in changing the results of the other pooled studies according to the Cochrane Handbook of systematic review [26].

We did not find a significant association between HPV and RB (OR: 12.2; 95% CI: 0.65–232; p = 0.09) (Figure 4). However, after removing the largest-weighted study, a significant association between HPV and RB was observed (OR: 45.9; 95% CI; 8.6–245; p < 0.001) (Figure 5).

FIGURE 4.

FIGURE 4

The association of Human papilloma virus and retinoblastoma (Shanghai, China. 2022). Notes: The data are represented with the odds ratio and the corresponding 95% confidence interval.

FIGURE 5.

FIGURE 5

Sensitivity analysis of the association of Human papilloma virus and retinoblastoma (Shanghai, China. 2022). Notes: Association is represented with the odds ratio and the corresponding 95% confidence interval.

HPV Genotype in RB

HPV 16 was the most common genotype presented in RB samples 23% (95% CI: 9–47), followed by HPV 18 10% (95% CI: 3–30) and the combined HPV 16–18 6% (95% CI: 0–50) (Supplementary Figures S2–S6).

Discussion

We found that the prevalence of HPV in RB was 15.6% and was the highest in Mexico followed by India. Among all strains of HPV, HPV 16 had the highest prevalence in RB. We did not find an association between HPV and RB; however, the association was prevalent after performing a sensitivity analysis.

Various studies had explored the prevalence of HPV in RB samples and a huge variability in the prevalence among all studies was found. Fuentes et al. [19] indicated that the prevalence of HPV in RB samples from Mexican patients was 82%. Furthermore, the study of Shetty et al, conducted in India, revealed that the prevalence of HPV in RB was 69% [23]. Similarly, Mohan et al. [10] demonstrated that 48% of the Indian samples of RB had HPV infection. Despite this high rate from many studies, the multicenter study that recruited RB samples from North America demonstrated no case of HPV infection in RB samples [12], and no events were found in the Korean RB samples [11]. To our knowledge, low socioeconomic status including education, residence, poor nutritional status, and poverty, together with life style behaviors, plays a vital role in the susceptibility to infection in low and low middle income countries [27, 28]. Of note, Naru et al. [20] demonstrated that RB patients with evident HPV infection were more likely to be of low socioeconomic status and of rural residence than their peers without HPV infection. Moreover, breast feeding duration and mean birth weight were lower in the HPV positive group rather than HPV negative group in Mexican children with RB [21]. These may be explanations as to why no cases of HPV infection were reported in RB samples in high income countries. However, this mechanism does not fully explain the absence of HPV infection in many studies conducted in low middle income countries [9, 18, 24].

In our analysis, HPV 16 was the most common genotype presented in RB tissues. The results were consistent with many studies reported in literature [7, 20, 22, 25]. However, in the study of Orjuela et al. [21] HPV 18 was the most represented genotype in tumor tissue. Moreover, low risk HPV stains were the least reported strains in RB tissue reported from Anand et al. [7]. High risk HPV strains are associated with the development of many cancers [29, 30]. In addition, the high risk HPV stains were associated with RB differentiation and progression [23].

We did not find a significant association between HPV and RB; however the association was presented when we excluded the study of Antoneli et al. [8]. In addition to being the largest weighted study in our analysis which contributed to approximately one-third of the total weight of our pooled OR, the study was different in defining their control status rather than other studies. Antoneli and colleagues selected normal retinal tissue samples from already diagnosed RB cases, not from other normal patients or patients having other diseases than RB such as the other three included studies in the association analysis [10, 19, 20]. Familial history of RB is a significant risk factor for RB development during the childhood period [1]. In RB cases where familial predisposition could not be obtained, searching for the possible cause is a matter of concern among ophthalmologists, especially with the high expected mortality in low and low middle income countries [1]. In the study of Orjuela et al. [21] nearly one-third of RB samples of children without a family history of RB had HPV infection. Shetty and colleagues represented that HPV was prevalent in non-familial cases of RB which supports the direct link of HPV infection and the development of RB [23]. Tumor suppressor genes are essential for preventing cancer development. HPV infection may induce RB through the direct inhibition of the tumor suppressor proteins and the induction of mutation that is necessary for tumor growth and progression [5, 31].

Intensive efforts have been devoted to exploring the possible method of HPV infection in the eye before inducing RB. Different routes of transmission were identified including transmission during pregnancy, sexual contact, autoinoculation transmission, and transmission through fomites [3234]. Moreover, the mode of delivery is considered a major source of infection at which the neonates acquire infection through an infected birth canal [34]. This is supported by Naru et al. [20] results at which all RB samples infected with HPV were delivered vaginally compared to 72% of the HPV negative cases.

To our knowledge, HPV plays an important role in the deactivation of tumor suppressor genes, in particular pRB and p53 through the E7 and E6 proteins [35]. However, the study of Jeyaprakash et al. [18] indicated that all the DNA extracted from tumor tissues was not positive for HPV infection. Such results demonstrate that further analysis is required regarding the exact mechanism by which HPV induces RB, or the association, are due to other factors such as the genetic susceptibility, socioeconomic status, or family history of RB patients.

Our study had many limitations therefore our results should be taken with caution when interpreted by future studies. Firstly, all studies were cross-sectional in nature, which cannot determine the exact relationship between HPV and RB, therefore more prospective studies with long follow up periods are needed to confirm this association. Secondly, we found a significant heterogeneity between the included studies. Thirdly, many studies did not report the socioeconomic profile of the included patients which may have a significant effect of the association between RB and HPV. Fourthly, the selection of the control samples (healthy controls are preferred) is of extreme importance for measuring the true association between HPV and RB. Fifthly, all studies were of fair criterion, therefore caution should be considered when interpreting our results.

Author Contributions

HF: conceptualization, investigation, project administration, writing-original draft, writing-review and editing. YD: conceptualization, investigation, writing-original draft, writing-review and editing and supervision. All authors contributed to the article and approved the submitted version.

Conflict of Interest

The authors declare that they do not have any conflicts of interest.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.ssph-journal.org/articles/10.3389/ijph.2023.1605284/full#supplementary-material

References

  • 1. Dimaras H, Corson TW, Cobrinik D, White A, Zhao J, Munier FL, et al. Retinoblastoma. Nat Rev Dis primers (2015) 1(1):15021–3. 10.1038/nrdp.2015.21 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Jenkinson H. Retinoblastoma: Diagnosis and Management—The UK Perspective. Arch Dis Child (2015) 100(11):1070–5. 10.1136/archdischild-2014-306208 [DOI] [PubMed] [Google Scholar]
  • 3. Wong ES, Choy RW, Zhang Y, Chu WK, Chen LJ, Pang CP, et al. Global Retinoblastoma Survival and globe Preservation: a Systematic Review and Meta-Analysis of Associations with Socioeconomic and Health-Care Factors. Lancet Glob Health (2022) 10:e380–e389. 10.1016/S2214-109X(21)00555-6 [DOI] [PubMed] [Google Scholar]
  • 4. Fabian ID, Stacey AW, Foster A, Kivelä TT, Munier FL, Keren-Froim N, et al. Travel burden and Clinical Presentation of Retinoblastoma: Analysis of 1024 Patients from 43 African Countries and 518 Patients from 40 European Countries. Br J Ophthalmol (2021) 105(10):1435–43. 10.1136/bjophthalmol-2020-316613 [DOI] [PubMed] [Google Scholar]
  • 5. Muñoz N, Castellsagué X, de González AB, Gissmann L. Chapter 1: HPV in the Etiology of Human Cancer. Vaccine (2006) 24:S1–S10. 10.1016/j.vaccine.2006.05.115 [DOI] [PubMed] [Google Scholar]
  • 6. Duensing S, Münger K. Mechanisms of Genomic Instability in Human Cancer: Insights from Studies with Human Papillomavirus Oncoproteins. Int J Cancer (2004) 109(2):157–62. 10.1002/ijc.11691 [DOI] [PubMed] [Google Scholar]
  • 7. Anand B, Ramesh C, Appaji L, Kumari BS, Shenoy AM, Jayshree RS, et al. Prevalence of High-Risk Human Papillomavirus Genotypes in Retinoblastoma. Br J Ophthalmol (2011) 95(7):1014–8. 10.1136/bjo.2010.199802 [DOI] [PubMed] [Google Scholar]
  • 8. Antoneli CB, Ribeiro KB, Sredni ST, Arias VE, Andreoli MA, de Camargo B, et al. Low Prevalence of HPV in Brazilian Children with Retinoblastoma. J Med Virol (2011) 83(1):115–8. 10.1002/jmv.21925 [DOI] [PubMed] [Google Scholar]
  • 9. Chauhan S, Sen S, Sharma A, Pushker N, Kashyap S, Chawla B, et al. Human Papillomavirus in Ocular Malignant Tumours: a Study from a Tertiary Eye Care centre in North India. Can J Ophthalmol (2019) 54(6):688–93. 10.1016/j.jcjo.2019.03.001 [DOI] [PubMed] [Google Scholar]
  • 10. Mohan N, Kandalam M, Pasricha G, Acharya P, Khetan V, Gopal L, et al. Detection of Human Papillomavirus DNA in Retinoblastoma Samples A Preliminary Study. J Pediatr Hematol Oncol (2009) 31(1):8–13. 10.1097/MPH.0b013e31818b373b [DOI] [PubMed] [Google Scholar]
  • 11. Ryoo NK, Kim JE, Choung HK, Kim N, Lee MJ, Khwarg SI. Human Papilloma Virus in Retinoblastoma Tissues from Korean Patients. Korean J Ophthalmol (2013) 27(5):368–71. 10.3341/kjo.2013.27.5.368 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Gillison R, Goshu E, Rushlow D, Chen N, Banister C, Creek KE, et al. Human Retinoblastoma Is Not Caused by Known pRb-Inactivating Human DNA Tumor Viruses. Int J Cancer (2007) 120(7):1482–90. 10.1002/ijc.22516 [DOI] [PubMed] [Google Scholar]
  • 13. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, et al. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies that Evaluate Health Care Interventions: Explanation and Elaboration. PLos Med (2009) 6(7):e1000100. 10.1371/journal.pmed.1000100 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Health NIo. Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies. National Heart, Lung, and Blood Institute (2014). Avaliable from: www.nhlbi.nih.gov/health-pro/guidelines/indevelop/cardiovascular-risk-reduction/tools/cohort (Accessed November 5, 2015). [Google Scholar]
  • 15. Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions (Identifying and Measuring Heterogeneity). England, UK: The Cochrane Collaboration; (2011). [Google Scholar]
  • 16. Egger M, Smith GD, Schneider M, Minder C. Bias in Meta-Analysis Detected by a Simple, Graphical Test. Bmj (1997) 315(7109):629–34. 10.1136/bmj.315.7109.629 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of Two Methods to Detect Publication Bias in Meta-Analysis. Jama (2006) 295(6):676–80. 10.1001/jama.295.6.676 [DOI] [PubMed] [Google Scholar]
  • 18. Jeyaprakash K, Shanthini T, Kim U, Muthukkaruppan V, Vanniarajan A. Human Papillomavirus in Retinoblastoma: A Tertiary Eye Care center Study from South India. Indian J Ophthalmol (2021) 69(8):2111–5. 10.4103/ijo.IJO_106_21 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Montoya-Fuentes H, Villar-Calvo V, Suarez-Rincon AE, Ornelas-Aguirre JM, Vazquez-Camacho G, Orbach-Arbouys S, et al. Identification of DNA Sequences and Viral Proteins of 6 Human Papillomavirus Types in Retinoblastoma Tissue. Anticancer Res (2003) 23(3):2853–62. [PubMed] [Google Scholar]
  • 20. Naru J, Aggarwal R, Singh U, Kakkar N, Bansal D. HPV-16 Detected in One-Fourth Eyes with Retinoblastoma: A Prospective Case-Control Study from North India. J Pediatr Hematol Oncol (2016) 38(5):367–71. 10.1097/MPH.0000000000000552 [DOI] [PubMed] [Google Scholar]
  • 21. Orjuela VP, Ridaura C, Lecona E, Leal C, Abramson DH, Orlow I, et al. Presence of Human Papilloma Virus in Tumor Tissue from Children with Retinoblastoma: an Alternative Mechanism for Tumor Development. Clin Cancer Res (2000) 6(10):4010–6. [PubMed] [Google Scholar]
  • 22. Palazzi JA, Cardinalli IA, Stangenhaus GP, Brandalise SR, Ferreira SA, Sobrinho JS, et al. Detection of Oncogenic Human Papillomavirus in Sporadic Retinoblastoma. Acta Ophthalmol Scand (2003) 81(4):396–8. 10.1034/j.1600-0420.2003.00112.x [DOI] [PubMed] [Google Scholar]
  • 23. Shetty KN, Banavali SD, Shet T, Joshi R, Qureshi S, Mulherkar R, et al. Evidence for the Presence of High Risk Human Papillomavirus in Retinoblastoma Tissue from Nonfamilial Retinoblastoma in Developing Countries. Pediatr Blood Cancer (2012) 58(2):185–90. 10.1002/pbc.23346 [DOI] [PubMed] [Google Scholar]
  • 24. Saktanasate P, Uiprasertkul M, Horthongkham N, Trinavarat A, Atchaneeyasakul LO. Human Papillomavirus DNA in Paraffin-Embedded Retinoblastoma. J Med Assoc Thailand (2018) 101(2):229–31. [Google Scholar]
  • 25. Javanmard M, Esghaei M, Naseripour M, Monavari SH, Bokharaei-Salim F, Sadeghipour A, et al. Molecular Evidence of Human Papillomaviruses in the Retinoblastoma Tumor. Virusdisease (2019) 30(3):360–6. 10.1007/s13337-019-00540-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Deeks JJ, Higgins JPT, Altman DG. Analysing Data and Undertaking Meta-Analyses (2023). Available from: https://training.cochrane.org/handbook/current/chapter-10 (Accessed March 2, 2022). [Google Scholar]
  • 27. Bouzid M, Kintz E, Hunter PR. Risk Factors for Cryptosporidium Infection in Low and Middle Income Countries: A Systematic Review and Meta-Analysis. PLoS Negl Trop Dis (2018) 12(6):e0006553. 10.1371/journal.pntd.0006553 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Kerr-Pontes LR, Barreto ML, Evangelista CM, Rodrigues LC, Heukelbach J, Feldmeier H. Socioeconomic, Environmental, and Behavioural Risk Factors for Leprosy in North-east Brazil: Results of a Case–Control Study. Int J Epidemiol (2006) 35(4):994–1000. 10.1093/ije/dyl072 [DOI] [PubMed] [Google Scholar]
  • 29. Duray A, Descamps G, Arafa M, Decaestecker C, Remmelink M, Sirtaine N, et al. High Incidence of High-Risk HPV in Benign and Malignant Lesions of the Larynx. Int J Oncol (2011) 39(1):51–9. 10.3892/ijo.2011.1031 [DOI] [PubMed] [Google Scholar]
  • 30. Haghshenas M, Golini-moghaddam T, Rafiei A, Emadeian O, Shykhpour A, Ashrafi GH. Prevalence and Type Distribution of High-Risk Human Papillomavirus in Patients with Cervical Cancer: a Population-Based Study. Infect Agents Cancer (2013) 8(1):20. 10.1186/1750-9378-8-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. zur Hausen H. Human Papillomaviruses in the Pathogenesis of Anogenital Cancer. Virology (1991) 184(1):9–13. 10.1016/0042-6822(91)90816-t [DOI] [PubMed] [Google Scholar]
  • 32. Smith EM, Ritchie JM, Yankowitz J, Swarnavel S, Wang D, Haugen TH, et al. Human Papillomavirus Prevalence and Types in Newborns and Parents: Concordance and Modes of Transmission. Sex Transm Dis (2004) 31:57–62. 10.1097/01.OLQ.0000105327.40288.DB [DOI] [PubMed] [Google Scholar]
  • 33. Watts DH, Koutsky LA, Holmes KK, Goldman D, Kuypers J, Kiviat NB, et al. Low Risk of Perinatal Transmission of Human Papillomavirus: Results from a Prospective Cohort Study. Am J Obstet Gynecol (1998) 178(2):365–73. 10.1016/s0002-9378(98)80027-6 [DOI] [PubMed] [Google Scholar]
  • 34. Tseng C-J, Liang C-C, Soong Y-K, Pao C-C. Perinatal Transmission of Human Papillomavirus in Infants: Relationship between Infection Rate and Mode of Delivery. Obstet Gynecol (1998) 91(1):92–6. 10.1016/s0029-7844(97)00593-0 [DOI] [PubMed] [Google Scholar]
  • 35. Narisawa-Saito M, Kiyono T. Basic Mechanisms of High-Risk Human Papillomavirus-Induced Carcinogenesis: Roles of E6 and E7 Proteins. Cancer Sci (2007) 98(10):1505–11. 10.1111/j.1349-7006.2007.00546.x [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials


Articles from International Journal of Public Health are provided here courtesy of Frontiers Media SA

RESOURCES